David Johnson

Prior to joining the Computational Chemical Biology (CCB) Core in 2016, Dr. Johnson was a member of John Karanicolas' lab at the University of Kansas. There, he worked to pioneer new virtual screening strategies for difficult drug targets. As Director of the CCB, he has been a co-author on dozens of publications, performing the design, execution, and analysis of computational experiments including virtual screening, hit-to-lead optimization, molecular modeling, and molecular dynamics.